TRAVOGEN

Poland

It is used to treat superficial fungal skin infections, such as ringworm of the hands, feet, groin, or genital area, as well as pityriasis versicolor and pityriasis rosea.

Brand name TRAVOGEN
Dosage form cream
Active substance / Dosage
Prescription type Prescription only
ATC code
Registration number 100477894
Manufacturer LEO Pharma A/S
TRAVOGEN cream

Frequently asked questions

How to use Travogen?

The cream should be applied locally to the affected skin, usually once daily. Treatment typically lasts from two to three weeks, and in more difficult cases, a doctor may recommend four weeks or longer. To prevent recurrence, it is advisable to continue application for at least two weeks after the symptoms have subsided.

When not to use this medicine?

Do not use it if you are allergic to isoconazole nitrate or any of the other ingredients of the product.

What are the possible side effects of Travogen?

Skin irritation or burning may occur most frequently. Less commonly, itching, excessive skin dryness, weeping changes, small blisters, dermatitis, swelling, or skin cracks may occur. Redness or allergic reactions may also occur.

Does the medicine affect the use of other contraceptives?

If the cream is applied to the genital area, some ingredients may damage condoms or intra-uterine devices, which may cause them to stop effectively protecting against pregnancy or sexually transmitted diseases.

Can the medicine be used during pregnancy or breastfeeding?

Pregnant women should consult a doctor, who will exercise caution when prescribing the medicine. Breastfeeding women may use it only if a doctor deems that the benefits to the mother outweigh the risks to the child. In such cases, the cream should not be applied to the area around the nipples.

What should you remember during treatment?

Maintaining hygiene is very important: underwear and towels should be changed and boiled daily, and in the case of athlete's foot, the spaces between the toes should be dried thoroughly. Contact of the medicine with the eyes should also be avoided.

Instructions for use

Package leaflet: Information for the patient

Warning! Keep the leaflet. Information on the immediate packaging in a foreign language.
Travogen
10 mg/g (1%), cream
Isoconazoli nitras
Please read carefully the entire leaflet before using the medicine, as it contains
important information for the patient.

  • Keep this leaflet so that you can read it again if necessary.
  • If you have any further questions, please consult your doctor or pharmacist.
  • This medicine has been prescribed for a specific individual. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
  • If the patient experiences any adverse reactions, including any not listed in this leaflet, inform the doctor, pharmacist or nurse. See section 4.

Table of contents:

  1. What Travogen is and what it is used for
  2. Important information before using Travogen
  3. How to use Travogen
  4. Possible side effects
  5. How to store Travogen
  6. Contents of the pack and other information

1. What Travogen is and what it is used for

Travogen cream is an antifungal medicine for topical application to the skin.
The active substance, isoconazole nitrate, exerts antifungal activity against various species of fungi
causing skin infections in humans, such as dermatophytes, yeasts, yeast-like fungi (including those
causing pityriasis versicolor), moulds, and fungi causing erythrasma.
Indications
Superficial fungal skin infections, e.g. tinea of hands, feet, groin, genital areas; pityriasis versicolor; erythrasma.

2. Important information before using Travogen

When not to use Travogen

  • if the patient is allergic to isoconazole nitrate or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

  • Before starting treatment with Travogen, discuss this with your doctor or pharmacist.
  • Avoid contact of the medicine with the eyes. If the medicine gets into the eyes, rinse immediately with plenty of water.
  • To avoid re-infection, personal underwear (including body and face towels) should be changed daily and boiled. Use of cotton products is recommended.
  • Effective treatment with Travogen depends on maintaining proper personal hygiene. In tinea pedis (athlete's foot), the interdigital spaces should be carefully dried after each washing. Socks and stockings should be changed daily.
  • If Travogen is used in the genital area, some of the excipients contained in this medicine may damage condoms and diaphragms. Therefore, they may become ineffective as contraceptive methods or for protection against sexually transmitted diseases, such as HIV infection. For further information, consult your doctor or pharmacist.

Travogen and other medicines

Inform your doctor or pharmacist about all medicines currently used, recently used, or planned to be used.

There are no studies regarding interactions between Travogen and other medicines.

Pregnancy, breastfeeding, and fertility

During pregnancy, while breastfeeding, if pregnancy is suspected, or when planning pregnancy, consult your doctor or pharmacist before using this medicine.

Pregnancy

Your doctor will exercise caution when prescribing this medicine to pregnant women.

Breastfeeding

Women who are breastfeeding may use Travogen only if, in the opinion of the doctor, the benefits to the mother outweigh the potential risks to the infant. If the doctor decides that Travogen should be used during breastfeeding, it should not be applied to the area of the nipples to prevent the infant from ingesting the medicine.

Effect on fertility

There are no data indicating that the use of Travogen affects fertility.

Driving and operating machinery

Travogen has no influence on the ability to drive motor vehicles or operate mechanical equipment.

Travogen contains cetostearyl alcohol

This ingredient may cause skin reactions (e.g. contact dermatitis).

3. How to use Travogen

This medicine should always be used according to the doctor's instructions. If in doubt, consult
your doctor or pharmacist.
Travogen is intended for topical use on the skin only.
Travogen is usually applied once daily to the affected skin area.
In fungal infections, topical treatment is typically administered for two to three weeks. In infections
that are difficult to treat (especially interdigital infections), the treatment period may be extended
by the doctor to four weeks. Longer treatment periods are also possible.
In fungal infections of the interdigital spaces of the hands and feet, it is recommended to place
a strip of gauze impregnated with Travogen between the fingers or toes.
To prevent recurrence of fungal infection, treatment should be continued for at least two weeks
after symptoms have resolved.
Very important for achieving a good treatment outcome with Travogen is daily adherence to
hygiene measures (see section "Warnings and precautions").
Children and adolescents
Dose adjustment is not necessary when Travogen is administered to infants, children, and adolescents.
Use of more than the recommended dose of Travogen
Single use of the medicine on a large skin surface area or accidental ingestion does not pose a risk
of acute poisoning. If in doubt, contact your doctor or pharmacist.
Missed dose of Travogen
Do not use a double dose to make up for a missed dose.
If a dose is missed, apply the next dose as soon as possible, then continue treatment according
to instructions.
If you have any further doubts regarding the use of this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
The side effects are listed below by frequency:

Common: may affect up to 1 in 10 people

  • Skin irritation or burning sensation at the application site.

Uncommon: may affect up to 1 in 100 people

  • Itching or excessive skin dryness at the application site, oozing lesions, small fluid-filled blisters (miliaria), skin inflammation (contact dermatitis).

Rare: may affect up to 1 in 1000 people

  • Swelling at the application site, skin fissures.

Frequency not known:

  • Redness (erythema) or blisters at the application site, allergic skin reactions.

Reporting of side effects
If any side effects occur, including any side effects not listed in this leaflet, inform your doctor, pharmacist or nurse. Side effects can also be reported directly to the Department of Monitoring Adverse Drug Reactions, Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 (22) 49 21 301
Fax: +48 (22) 49 21 309
Website: https://smz.ezdrowie.gov.pl
Reporting side effects helps provide more information on the safety of this medicine.

5. How to store Travogen

Do not store above 25°C.
Keep the medicine in a place out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the stated month.
Medicines must not be disposed of via wastewater or household waste. Ask your pharmacist what to do with medicines no longer in use. This will help protect the environment.

6. Contents of the packaging and other information

What Travogen contains

  • The active substance is isoconazole nitrate. 1 g of cream contains 10 mg of isoconazole nitrate.
  • Other components are: polysorbate 60, sorbitan stearate, cetostearyl alcohol, liquid paraffin, white soft paraffin, purified water.

What Travogen looks like and contents of the pack
Travogen is a white to slightly yellowish, opaque cream.
The packaging consists of a tube containing 15 g or 30 g of cream, placed in a cardboard box.
For more detailed information, please contact the responsible party or the parallel importer.
Marketing Authorisation Holder in Greece, country of export:
LEO Pharma A/S
Industriparken 55
DK-2750 Ballerup
Denmark
Manufacturer:
LEO Pharma Manufacturing Italy S.r.l.
Via E. Schering 21, 20054 Segrate
Milan, Italy
Parallel Importer:
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Repackaged in:
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Marketing Authorisation Number in Greece, country of export: 32260/5-9-1995
103340/19/03-02-2020
Parallel Import Licence Number: 434/22

Similar drugs

The original data is available in the language of the country of manufacture.

Data source: Register of Medicinal Products of Poland (URPL)

Data last verified: September 01, 2026